82 results match your criteria: "Puerta de Hierro Research Institute[Affiliation]"
AIDS Rev
October 2023
UNIR Health Sciences, School and Medical Center, Madrid, Spain.
AIDS Rev
October 2023
Regional Public Health Laboratory, Emergency Hospital Isabel Zendal, Madrid. Spain.
Sexually transmitted infections (STIs) have become the second in the global rating of infectious diseases after respiratory infections. Globally, over 1 million, new STI is diagnosed every day. Although four conditions are the most representative and of obligatory declaration (gonorrhea, syphilis, chlamydia, and human immunodeficiency virus [HIV]), there are many other prevalent STI, including trichomona, herpes simplex, papillomavirus, and viral hepatitis.
View Article and Find Full Text PDFJ Clin Virol
October 2023
UNIR Health Sciences School & Medical Center, Madrid, Spain. Electronic address:
Background: Before the advent of COVID-19 vaccines, hospitalizations due to SARS-CoV-2 infection during 2020 collapsed most medical centers worldwide. Disruptions in health care for clinical conditions other than COVID-19 were not uniform. Herein, we report the impact of COVID-19 on hospitalizations due to viral hepatitis in Spain.
View Article and Find Full Text PDFAntioxidants (Basel)
January 2023
Precision Nutrition and Cardiometabolic Health, IMDEA Food Institute, CEI UAM+CSIC, 28049 Madrid, Spain.
Viral infections activate the innate immune response and the secretion of inflammatory cytokines. They also alter oxidative stress markers, which potentially can have an involvement in the pathogenesis of the disease. The aim of this research was to study the role of the oxidative stress process assessed through lactate dehydrogenase (LDH) on the severity of COVID-19 measured by oxygen saturation (SaO) and the putative interaction with inflammation.
View Article and Find Full Text PDFBackground: Chronic hepatitis B virus (HBV) infection is a major cause of decompensated cirrhosis and liver cancer worldwide. Newborn HBV vaccination was implemented in Spain two decades ago, and potent oral antivirals entecavir and tenofovir were introduced around 2007.
Aim: To assess the clinical benefits of these interventions nationwide.
Lupus Sci Med
October 2022
Autoimmune Diseases Research Unit, BioCruces Bizkaia Health Research Institute, Cruces University Hospital, Barakaldo, Spain.
Objective: Infections are a common complication of SLE. Our objective was to evaluate their causes and impact on the survival of patients with SLE.
Methods: Analysis of the admissions and death causes in patients diagnosed with SLE from the Spanish Hospital Discharge Database and the infection-related deaths of the Spanish population from the National Statistical Institute, between 2016 and 2018.
Infez Med
September 2022
UNIR Health Sciences School & Medical Center, Pozuelo de Alarcón, Madrid, Spain.
The battle against human viral infections has historically relied on two medical strategies, namely vaccines to protect from contagion and antivirals to treat infected patients. In the absence of vaccines, antivirals have occasionally been used as peri-exposure prophylaxis, given either before (pre-exposure prophylaxis) or right after (post-exposure prophylaxis). In an unprecedented way, the use of antiretrovirals as chemoprophylaxis has triumphed in the HIV field.
View Article and Find Full Text PDFJ Crit Care
December 2022
Internal Medicine Service, IDIPHIM (University Hospital Puerta de Hierro Research Institute), Hospital Universitario Puerta de Hierro Majadahonda, C/Joaquín Rodrigo 2, Majadahonda, Madrid, Spain.
Liver Int
August 2023
Public Health Regional Laboratory, Hospital Isabel Zendal, Madrid, Spain.
Hepatitis delta virus (HDV) is a defective agent that only infects individuals with hepatitis B virus (HBV). Around 5-10% of chronic hepatitis B patients worldwide are superinfected with HDV, which means 15-25 million people. Hepatitis delta is the most severe of all chronic viral hepatitis, leading to cirrhosis, liver cancer and/or transplantation in most patients.
View Article and Find Full Text PDFJ Crit Care
October 2022
Internal Medicine Service, IDIPHIM (University Hospital Puerta de Hierro Research Institute), Hospital Universitario Puerta de Hierro Majadahonda. C/Joaquín Rodrigo 2, Majadahonda, Madrid, Spain.
Purpose: To evaluate Red blood cell distribution width (RDW) as a sepsis prognostic biomarker.
Methods: 203 septic patients admitted to the ICU. Analysis of RDW dynamics, hospital mortality discrimination ability and the added value when incorporated to the SOFA, LODS, SAPS-II and APACHE-II scores using the AUC-ROC.
Hepatol Int
October 2022
UNIR Health Sciences School and Medical Center, Calle Almansa 101, 28040, Madrid, Spain.
Background: Chronic viral hepatitis B, C, and D are the main causes of decompensated cirrhosis and liver cancer worldwide. Newborn HBV vaccination was implemented more than 2 decades ago in most EU countries. Furthermore, potent oral antivirals have been available to treat HBV for 15 years and to cure HCV since 2014.
View Article and Find Full Text PDFJ Clin Virol
August 2022
Servicio de Microbiología, Microbiology Department, Complexo Hospitalario Universitario de Santiago (CHUS), Instituto de Investigación Sanitaria de Santiago (IDIS), TravesiaChoupanasn, Santiago de Compostela 15705, Spain; Microbiology Department, Medical School, Santiago de Compostela University (USC), Santiago de Compostela, Spain. Electronic address:
Background: Hepatitis B virus (HBV) comprises 9 genotypes and multiple subgenotypes that depict differences in geographic distribution, clinical outcome and response to antiviral therapy. However, the molecular epidemiology of HBV geno/subgenotypes is globally scarce. In Spain, HBV genotype D seems to be more prevalent in the northwestern regions compared to the rest of the country for unclear reasons.
View Article and Find Full Text PDFChronic hepatitis C virus (HCV) infection is major cause of decompensated cirrhosis and liver cancer. The advent of curative new antiviral therapies since year 2015 has dramatically improved the prognosis of HCV patients. The real-life clinical benefits at country level of these therapies have not yet been assessed.
View Article and Find Full Text PDFJ Transl Autoimmun
May 2022
Systemic Autoimmune Diseases Unit, Internal Medicine Service, IDIPHIM (University Hospital Puerta de Hierro Research Institute), Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain.
Background And Objectives: Systemic Lupus Erythematosus (SLE) follow-up is based on clinical, and analytical parameters. We aimed to determine the differences between the Neutrophil-to-lymphocyte ratio (NLR), Platelet-to-lymphocyte ratio (PLR) and Red blood cell distribution width (RDW) between SLE patients and healthy controls and to assess their association with anemia status, classical inflammatory biomarkers and cytokines, disease activity, SLE related factors and treatment received for SLE.
Methods: Seventy-seven patients with SLE according to 2012 SLICC criteria and 80 healthy controls were included.
Ann Palliat Med
August 2022
Internal Medicine Service, IDIPHIM (University Hospital Puerta de Hierro Research Institute), Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain.
Background: Red blood cell distribution width (RDW) could reflect interleukin-6 (IL-6) systemic activity since anisocytosis represents the inhibition of erythropoiesis, leaded by the hyperinflammatory background. Our objective was to analyze RDW performance to predict outcome in coronavirus disease 2019 (COVID-19) acute respiratory distress syndrome (ARDS).
Methods: Retrospective observational study including 173 patients with COVID-19-associated ARDS.
Clin Transl Sci
July 2022
Systemic Autoimmune Diseases Unit, Internal Medicine Service, IDIPHIM (University Hospital Puerta de Hierro Research Institute), Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain.
We aimed to explore the role of interleukin (IL)-6, interferon-gamma (IFNγ), IL-10, and tumor necrosis factor (TNF) as predictors of systemic lupus erythematosus (SLE) clinical and serological activity, and their correlation with the treatment received. We performed a retrospective analysis of 77 patients with SLE according to the 2012 Systemic Lupus International Collaborative Clinics (SLICC) criteria. The outcomes were serological activity (SA), active disease (AD), complete remission (CR), the low-disease activity state (LDAS), and immunosuppressive treatment.
View Article and Find Full Text PDFClin Exp Rheumatol
November 2022
Autoimmune Diseases Research Unit, BioCruces Bizkaia Health Research Institute, UPV/EHU, Bizkaia, Spain.
Objectives: To determine the burden and impact of cardiovascular risk factors (CRF) in antiphospholipid syndrome (APS) patients.
Methods: Analysis of the patients diagnosed with APS identified in the Spanish Hospital Discharge Database between 2016 and 2017. We analysed the admissions due to arterial (ATE) and venous thromboembolic events (VTE) and evaluated the incidence and the attributed risk of each CRF.
AIDS Rev
March 2022
Department of Pharmacology and Experimental Neuroscience, College of Medicine, University of Nebraska, Medical Center, NE, USA.
Vaccines and antivirals are the classical weapons deployed to contain, prevent, and treat life-threatening viral illnesses. Specifically, for SARS-CoV-2 infection, vaccines protect against severe COVID-19 disease manifestations and complications. However, waning immunity and emergence of vaccine escape mutants remains a growing threat.
View Article and Find Full Text PDFBackground: The prognosis of HIV infection dramatically improved after the introduction of triple antiretroviral therapy 25 years ago. Herein, we report the impact of further improvements in HIV management since then, looking at all hospitalizations in persons with HIV (PWH) in Spain.
Methods: A retrospective study using the Spanish National Registry of Hospital Discharges.
Int J Infect Dis
November 2021
UNIR Health Sciences School and Medical Center, Madrid, Spain. Electronic address:
Background: The advent of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines has been associated with a significant decline in coronavirus disease 2019 (COVID-19) hospitalizations and deaths. However, little is known about the benefits experienced by different population groups and/or using distinct vaccines.
Methods: The Spanish public registry was analyzed to examine associations between weekly vaccination scale-up and the incidence of COVID-19 hospitalizations by age, sex, and vaccine modality.
Background: Hepatitis delta is the most aggressive form of chronic viral hepatitis. We examined the clinical burden, epidemiological features and time trends for hepatitis delta patients hospitalized in Spain during the last two decades.
Methods: Retrospective, observational study using the Spanish National Registry of Hospital Discharges.
J Int Assoc Provid AIDS Care
August 2021
Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California, San Diego, CA, USA.
Fifty-four consecutive persons with HIV co-infected with hepatitis C virus (HCV) and liver decompensation were treated with direct-acting antivirals (DAA). The HCV treatment was delivered using a multidisciplinary HIV-coinfection model of care integrating sub-specialty services in 3 countries. Of those treated, 91% (95% confidence interval, 80.
View Article and Find Full Text PDFInt J Infect Dis
June 2021
Consejería de Sanidad, Comunidad Autónoma, Madrid, Spain.
A third wave of COVID-19 occurred after Christmas 2020 in Madrid, one of the European pandemic epicenters. We noticed 6 major differential features to previous waves. First, household contacts were a large proportion of cases.
View Article and Find Full Text PDF